Stayble Therapeutics AB

Stayble Therapeutics AB

Project management regarding communication in connection with the company’s rights issue in 2021.

Client: Stayble Therapeutics AB
Type: Preferential rights issue

About Stayble Therapeutics

Stayble Therapeutics is a Swedish life science company developing an injectable treatment against chronic low back pain triggered by disc degeneration. Stayble Therapeutics initiated a multinational clinical phase 2b trial in 2020.